At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 118 enrolled
Drug / intervention
Ivermectin +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Impact of Community Scabies Treatment on Head Lice Prevalence in the Solomon Islands
London School of Hygiene and Tropical Medicine·interventional·Posted Aug 1, 2017·Updated Jun 14, 2019
In Brief
A Phase 3 clinical trial evaluating Ivermectin, Permethrin 5%, and 1 other intervention for Scabies and Head Lice. Completed, enrolled 118 participants across 1 site.
Detailed Summary
This is a pilot study evaluating if treatment for scabies also treats headlice in the same community
Study Details
Timeline
Phase 3CompletedFinished
201820192020202120222023202420252026
First PostedAug 2017
Enrollment StartAug 2017
Primary CompletionDec 2017
Study CompletionFeb 2018
TodayJul 2026
First PostedAug 1, 2017
Enrollment StartAug 1, 2017
Primary CompletionDec 31, 2017
Study CompletionFeb 28, 2018
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 8.9 years ago
Interventions
Ivermectindrug
A single weight based dose of ivermectin
Permethrin 5%drug
Permethrin cream is used in conjunction with Malathion shampoo when ivermectin is contra-indicated
Malathion Shampoo 0.5%drug
Permethrin cream is used in conjunction with Malathion shampoo when ivermectin is contra-indicated